IQVIA Holdings Inc.
IQVIA Holdings Inc. is a global provider of advanced analytics, technology, and clinical research services.
It helps healthcare companies drive innovation and improve patient outcomes.

Join Our Programs
Our clients trust us for our expert advice and in-depth market analysis. Discover our services to gain more knowledge on investing.
Stock Market Webinar
Join our Stock Market Webinar to gain clear, actionable insights into current market trends. Learn how to analyse data, interpret signals, and make informed investment decisions with confidence. Designed for both beginners and experienced investors, this session delivers practical knowledge you can apply immediately.

Performance
In 2024, IQVIA Holdings Inc. reported a 2.8% year-over-year increase in annual revenue, reaching $15.405 billion, with fourth-quarter revenue of $3.958 billion, up 2.3% from the previous year. The company achieved a GAAP net income of $1.373 billion for the year, marking a 1.1% rise, and adjusted net income of $2.042 billion, up 7.4%. Adjusted diluted earnings per share for the year were $11.13, a 9.1% increase. Adjusted EBITDA for 2024 was $3.684 billion, reflecting a 3.2% growth. The Technology & Analytics Solutions segment led with a 9.5% constant currency revenue growth in Q4, while the Research & Development Solutions segment experienced a slight decline. The company also reported record free cash flow of $721 million in Q4, contributing to a 49% year-over-year increase in free cash flow for the year.
Quality of Earnings
The company demonstrates strong adherence to General Accounting Principles, with financial reports that conform to GAAP, are decision-useful, sustainable, and offer returns exceeding the cost of capital. There have been no recent changes to accounting policies, and all required financial reports are submitted on time. Revenue quality is also robust, marked by high predictability—with a substantial portion of clients returning year after year—strong profitability with gross margins exceeding 70%, diversified income sources with no client accounting for more than 15% of revenue, and clear growth in both revenue and net income. Additionally, there are no significant financial report warning signs: earnings contain minimal accrual components, do not narrowly beat benchmarks in a suspicious pattern, and revenue is not recognized prematurely. Expenses are not misrepresented, audit opinions are unqualified, goodwill is properly assessed, and the company does not rely on aggressive accounting tactics such as related-party transactions or off-balance-sheet debt. Operating ccash flows align with net income, earnings are recurring and persistent, and there is no history of restatements or enforcement actions, reinforcing the reliability and quality of the company’s financial reporting.

Company Summary
IQVIA Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, helping healthcare organizations accelerate innovation and improve patient outcomes.
